Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes in patients with overweight and obesity. This study will involve a 6-month long commitment where participants will be expected to use an mHealth app daily, weigh themselves and check their fasting blood glucose levels every morning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
February 3, 2023
CompletedFirst Posted
Study publicly available on registry
February 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2028
October 2, 2025
September 1, 2025
5 years
February 3, 2023
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Effectiveness of mHealth apps at changing bodyweight assessed by bodyweight measurements over 6 months
Determine if the mhealth app is an effective weight loss modality compared to standard weight loss program (control) Outcome measure will be body weight in kg
3 months
Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire
Compare and determine which intervention promotes self-efficacy in weight management. Reporting will be on a scale of 0-100, with higher scores indicating higher self-efficacy
3 months
Long-term change in diabetes via fasting blood glucose
Compare and determine which intervention elicits the most change towards diabetes via fasting blood glucose Outcome measure will be fasting blood glucose
3 months
Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire
Comparing the two arms to determine which leads to greater quality of life (QOL) Measures will be reported on a scale of 1-5 across four domains. Scores will be converted to a scale of 0-100
3 months
Study Arms (2)
Healthi
EXPERIMENTALControl
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Between the age of 18-64
- BMI ≥ 25
- Owns or has access to a bathroom weight scale
- Owns a smartphone and willing to download mobile app
You may not qualify if:
- On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.
- Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are okay
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Diego State University
San Diego, California, 92182, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2023
First Posted
February 14, 2023
Study Start
January 1, 2023
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 31, 2028
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share